A carregar...
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
The factor Xa inhibitor apixaban is one of the novel anticoagulants to emerge as alternatives to long-standing standards of care that include low-molecular-weight heparin and warfarin. The development of apixaban reflects a strategy to optimize the clinical pharmacology profile, dosing posology, tri...
Na minha lista:
| Publicado no: | Ann N Y Acad Sci |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BlackWell Publishing Ltd
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4260137/ https://ncbi.nlm.nih.gov/pubmed/25377080 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/nyas.12567 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|